【24h】

CT-guided percutaneous cryoablation for osteoid osteoma: Initial experience in adults

机译:CT引导下经皮冷冻消融治疗骨样骨瘤:成人的初步经验

获取原文
获取原文并翻译 | 示例
       

摘要

OBJECTIVE. The purpose of this study was to investigate the safety and efficacy of CT-guided percutaneous cryoablation for the treatment of osteoid osteoma in adults. MATERIALS AND METHODS. A retrospective case series over a 30-month period involved 10 consecutive adult patients (nine male and one female patients; mean age, 27.9 years; age range, 16-49 years) who underwent CT-guided percutaneous cryoablation for management of osteoid osteoma. Clinical and technical success was evaluated with postprocedure MRI at 4-5 weeks and with digital numeric pain scores taken before and immediately after the procedure, as well as at primary follow-up (4-10 weeks; average, 5 weeks) and secondary follow-up (23-29 weeks; average, 24 weeks). RESULTS. Clinical and technical success rates were 100%. Average digital numeric pain scores were 7.4 before the procedure, 1.5 after procedure, 0.5 at the primary follow-up, and 0.3 at secondary follow-up. No minor or major complications were noted during the procedure, recovery period, primary follow-up, or secondary follow-up. CONCLUSION. CT-guided percutaneous cryoablation is safe and effective in the treatment of osteoid osteoma in adults.
机译:目的。这项研究的目的是探讨CT引导经皮冷冻消融术治疗成人类骨瘤的安全性和有效性。材料和方法。在一个为期30个月的回顾性病例系列中,连续10例成人患者(9例男性和1例女性患者;平均年龄27.9岁;年龄范围16-49岁)接受了CT引导下经皮冷冻消融术治疗类骨性骨瘤。在手术后4-5周通过MRI评估临床和技术成功率,并在手术前和手术后以及在初次随访(4-10周;平均5周)和继发随访时进行数字化疼痛评分评估(23-29周;平均24周)。结果。临床和技术成功率均为100%。术前平均数字疼痛评分为7.4,术后1.5,初次随访时为0.5,二次随访时为0.3。在手术,恢复期,初次随访或二次随访中均未发现轻微或重大并发症。结论。 CT引导的经皮冷冻消融治疗成人类骨质骨瘤是安全有效的。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号